Jump to ContentJump to Main Navigation
The Delegated Welfare State$

Kimberly J. Morgan and Andrea Louise Campbell

Print publication date: 2011

Print ISBN-13: 9780199730346

Published to Oxford Scholarship Online: January 2012

DOI: 10.1093/acprof:oso/9780199730346.001.0001

(p.xi) List of Tables

Source:
The Delegated Welfare State
Publisher:
Oxford University Press

  1. Table 2.1 Forms of Delegated Governance 24

  2. Table 2.2 Desire for Increased Government Spending among All Respondents, Conservatives, Republicans, and Government Skeptics, 2008 39

  3. Table 2.3 Government Spending Preferences among Government Skeptics in Low and High Government Trust Years 44

  4. Table 7.1 Effects of Part D or Medicare Advantage Enrollment on Group Consciousness and Attitudes toward State and Market Roles, December 2005 to May 2007 174

  5. Table 7.2 Issue Ownership, December 2005 (Baseline) and May 2007 (Follow-up) 179

  6. Table 7.3 Predicting Who Gives the Republican Party Credit for the New Drug Benefit, May 2007 181

  7. Table 7.4 Predicting Pro-Republican Attitudes on Prescription Drugs and Making Right Decisions on Medicare and Government, May 2007 184

  8. Table 7.5 Medicare-option versus private Drug Plans, May 2007 193

  9. Table 8.1 Part D Experiences of Vulnerable Populations 215

  10. Table A.1 Knowledge Networks 65+ Year-Old Panel vs. Current Population Survey 239

  11. Table A.2 MMA Panel Survey (Internet) vs. Kaiser Family Foundation Survey (Telephone) 240

  12. Table B.1 Effects of Part D or Medicare Advantage Enrollment on Group Consciousness and Attitudes toward State and Market Roles, December 2005, May 2007, February 2009, among Respondents Who Remained in Third Wave 243

  13. Table B.2 Effects of Part D or Medicare Advantage Enrollment on Group Consciousness and Attitudes toward State and Market Roles: Multivariate Analysis 246

  14. Table B.3 Issue Ownership among Wave 3 Respondents 250

  15. Table B.4 Medicare-Related Participatory Acts among Wave 3 Respondents 252

  16. Table B.5 Predicting Drug Plan Switching, Problems, Affordability, and Financial Security, May 2007 252

(p.xii)